Novo Nordisk Acquires Embark Biotech to Boost Obesity and Cardiometabolic Drug Development
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced the purchase of compatriot Embark Biotech,...
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced the purchase of compatriot Embark Biotech,...